GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Pretax Margin %

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Pretax Margin % : 5.51% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Takeda Pharmaceutical Co's Pre-Tax Income for the three months ended in Dec. 2023 was $425 Mil. Takeda Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was $7,718 Mil. Therefore, Takeda Pharmaceutical Co's pretax margin for the quarter that ended in Dec. 2023 was 5.51%.

The historical rank and industry rank for Takeda Pharmaceutical Co's Pretax Margin % or its related term are showing as below:

TAK' s Pretax Margin % Range Over the Past 10 Years
Min: -8.18   Med: 8.38   Max: 12.27
Current: 3.56


TAK's Pretax Margin % is ranked worse than
52.45% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 4.555 vs TAK: 3.56

Takeda Pharmaceutical Co Pretax Margin % Historical Data

The historical data trend for Takeda Pharmaceutical Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Pretax Margin % Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.08 -1.85 11.45 8.48 9.31

Takeda Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.77 5.01 12.76 -9.20 5.51

Competitive Comparison of Takeda Pharmaceutical Co's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Pretax Margin % falls into.



Takeda Pharmaceutical Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Takeda Pharmaceutical Co's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=2806.209/30131.292
=9.31 %

Takeda Pharmaceutical Co's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=425.471/7717.561
=5.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co  (NYSE:TAK) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Takeda Pharmaceutical Co Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Headlines

From GuruFocus